The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain

Creative Commons License

Erken N., Gunay F. S. D., SOYSAL P., IŞIK A. T.

CLINICAL INTERVENTIONS IN AGING, vol.15, pp.691-693, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15
  • Publication Date: 2020
  • Doi Number: 10.2147/cia.s252229
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, AgeLine, EMBASE, MEDLINE, Directory of Open Access Journals
  • Page Numbers: pp.691-693
  • Keywords: chemobrain, Theracurmin, elderly, cognitive impairment, cancer, IMPAIRMENT, CURCUMIN, CANCER
  • Bezmialem Vakıf University Affiliated: Yes


Chemobrain is one of the problems that may arise during or after treatment and there is currently no specific treatment for this condition. Our case was a 76-year-old female patient who presented to our clinic with complaints of forgetfulness that did not affect daily living activities for the last year. Breast cancer was diagnosed in 2013 and she has been receiving anastrozole treatment for 6 years after local mass excision surgery and radiotherapy. After a comprehensive geriatric evaluation, cognitive impairment due to systemic cancer therapy was detected and treatment was started with Theracurmin 90 mg twice a day therapy. After 3-months of Theracurmin therapy, she had no cognitive improvement during the follow-up. This case report demonstrated that Theracurmin treatment may be a new option for chemobrain.